Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04896697
Title XTX101 Monotherapy and XTX101 and Pembrolizumab Combination Therapy in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Xilio Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
California Cancer Associates for Research and Excellence, cCARE RECRUITING Encinitas California 92024 United States Details
California Cancer Associates for Research and Excellence, cCARE RECRUITING San Marcos California 92069 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists RECRUITING Orlando Florida 32827 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Carolina BioOncology Institute COMPLETED Huntersville North Carolina 28078 United States Details
University of Pittsburgh Medical Center- Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Next Oncology RECRUITING Austin Texas 78758 United States Details
Mary Crowley Cancer Research COMPLETED Dallas Texas 75230 United States Details
Tranquil Clinical Research RECRUITING Webster Texas 77598 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field